Results
eNauka >
Rezultati >
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study
Naziv  : | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study | Autori  : | Naismith, Robert T; ...; Obradovic, Dragana V; ...; (broj, koautora 20) | Godina: | 2020 | Publikacija: | MULTIPLE SCLEROSIS JOURNAL | ISSN: | 1352-4585 Multiple Sclerosis Pretraži identifikator |
Tip rezultata: | Naučni članak | Kolacija: | vol. 26 br. 13 str. 1729-1739 | DOI: | 10.1177/1352458519881761 | WoS-ID: | 000495329200001 | Scopus-ID: | 2-s2.0-85074850025 | PMID: | 31680631 | PMCID: | PMC7604551 | URI: | https://enauka.gov.rs/handle/123456789/827904 | Projekat: | Alkermes Inc (Waltham, MA, USA) Biogen (Cambridge, MA, USA) |
Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.